Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changping Hu

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Therapeutic Advances in Cardiovascular Disease|November 18, 2011
Decorin in atherosclerosisSandeep Singla, Changping Hu, Adam Mizeracki, et al.
Cardiovascular Drugs and Therapy|October 14, 2011
LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complicationsMeiling Yan, Jawahar L Mehta, Weifang Zhang, et al.
Biochemical and Biophysical Research Communications|September 17, 2013
LOX-1 deletion and macrophage trafficking in atherosclerosisZufeng Ding, Adam Milton Mizeracki, Changping Hu, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|February 11, 2025
Methods for establishing animal models of persistent pulmonary hypertension of the newborn: A systematic literature analysisMingyuan Cai, Shuhan Zhou, Ping Luo, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|February 9, 2026
<i>LOX</i><b><i>-</i></b><i>1</i> gene knockout improves metabolic dysfunction<b>-</b>associated steatohepatitis in miceRuihua Huang, Yongyu Yang, Shuhan Zhou, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|June 5, 2026
Solamargine alleviates liver fibrosis by regulating YAP signaling in hepatic stellate cellsRuihua Huang, Alshami Mohammed Abdulaziz Yahya Ali, Xiaoyun Zhu, et al.
Toxicology and Applied Pharmacology|November 26, 2025
Nitazoxanide reverses pulmonary vascular remodeling in pulmonary hypertension by targeting the IMPA1-RAGE signaling axisDi Wang, Ning Huang, Mingyuan Cai, et al.
Cardiovascular Drugs and Therapy|September 14, 2011
Novel concepts in the genesis of hypertension: role of LOX-1Ping Luo, Meiling Yan, Edward D Frohlich, et al.
Behavioral Sciences (Basel, Switzerland)|July 27, 2024
Study on the Psychological Effects of Intangible Cultural Heritage Advertising with Different Degrees of Situational InvolvementRuiying Kuang, Changping Hu, Shiyu Huo, et al.
Toxicology and Applied Pharmacology|July 2, 2026
Corrigendum to "Nitazoxanide reverses pulmonary vascular remodeling in pulmonary hypertension by targeting the IMPA1-RAGE signaling axis" [Toxicology and Applied Pharmacology 507 (2026) 117657]Di Wang, Ning Huang, Mingyuan Cai, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Therapeutic Advances in Cardiovascular Disease|November 18, 2011
Decorin in atherosclerosisSandeep Singla, Changping Hu, Adam Mizeracki, et al.
Cardiovascular Drugs and Therapy|October 14, 2011
LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complicationsMeiling Yan, Jawahar L Mehta, Weifang Zhang, et al.
Biochemical and Biophysical Research Communications|September 17, 2013
LOX-1 deletion and macrophage trafficking in atherosclerosisZufeng Ding, Adam Milton Mizeracki, Changping Hu, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|February 11, 2025
Methods for establishing animal models of persistent pulmonary hypertension of the newborn: A systematic literature analysisMingyuan Cai, Shuhan Zhou, Ping Luo, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|February 9, 2026
<i>LOX</i><b><i>-</i></b><i>1</i> gene knockout improves metabolic dysfunction<b>-</b>associated steatohepatitis in miceRuihua Huang, Yongyu Yang, Shuhan Zhou, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|June 5, 2026
Solamargine alleviates liver fibrosis by regulating YAP signaling in hepatic stellate cellsRuihua Huang, Alshami Mohammed Abdulaziz Yahya Ali, Xiaoyun Zhu, et al.
Toxicology and Applied Pharmacology|November 26, 2025
Nitazoxanide reverses pulmonary vascular remodeling in pulmonary hypertension by targeting the IMPA1-RAGE signaling axisDi Wang, Ning Huang, Mingyuan Cai, et al.
Cardiovascular Drugs and Therapy|September 14, 2011
Novel concepts in the genesis of hypertension: role of LOX-1Ping Luo, Meiling Yan, Edward D Frohlich, et al.
Behavioral Sciences (Basel, Switzerland)|July 27, 2024
Study on the Psychological Effects of Intangible Cultural Heritage Advertising with Different Degrees of Situational InvolvementRuiying Kuang, Changping Hu, Shiyu Huo, et al.
Toxicology and Applied Pharmacology|July 2, 2026
Corrigendum to "Nitazoxanide reverses pulmonary vascular remodeling in pulmonary hypertension by targeting the IMPA1-RAGE signaling axis" [Toxicology and Applied Pharmacology 507 (2026) 117657]Di Wang, Ning Huang, Mingyuan Cai, et al.
Pageof 6